Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00541_DB01149> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00541_DB01149 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00541_DB01149 label "DDI between Vincristine and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB00541_DB01149]" assertion.
- drugbank_resource:DB00541_DB01149 identifier "drugbank_resource:DB00541_DB01149" assertion.
- drugbank_resource:DB00541_DB01149 title "DDI between Vincristine and Nefazodone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nefazodone is initiated, discontinued or dose changed." assertion.